Terms: = Uterine cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
193 results:
1. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.
Hu Z; Wu Z; Liu W; Ning Y; Liu J; Ding W; Fan J; Cai S; Li Q; Li W; Yang X; Dou Y; Wang W; Peng W; Lu F; Zhuang X; Qin T; Kang X; Feng C; Xu Z; Lv Q; Wang Q; Wang C; Wang X; Wang Z; Wang J; Jiang J; Wang B; Mills GB; Ma D; Gao Q; Li K; Chen G; Chen X; Sun C
Nat Genet; 2024 Apr; 56(4):637-651. PubMed ID: 38565644
[TBL] [Abstract] [Full Text] [Related]
2. Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
Khan NG; Adiga D; Rai PS; Kabekkodu SP
Toxicology; 2024 May; 504():153791. PubMed ID: 38555994
[TBL] [Abstract] [Full Text] [Related]
3. Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.
Stan A; Bosart K; Kaur M; Vo M; Escorcia W; Yoder RJ; Bouley RA; Petreaca RC
PLoS One; 2024; 19(2):e0299114. PubMed ID: 38408048
[TBL] [Abstract] [Full Text] [Related]
4. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
[TBL] [Abstract] [Full Text] [Related]
5. Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and ctnnb1 Translocation : A Report of 3 Cases.
Boyraz B; da Cruz Paula A; Deveraux KA; Tran I; da Silva EM; Young RH; Snuderl M; Weigelt B; Oliva E
Am J Surg Pathol; 2023 Nov; 47(11):1285-1290. PubMed ID: 37584555
[TBL] [Abstract] [Full Text] [Related]
6. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
7. ctnnb1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract] [Full Text] [Related]
8. Corded and hyalinized endometrioid carcinoma: Summary of clinical, histological, immunohistochemical and molecular data.
Travaglino A; Arciuolo D; Santoro A; Raffone A; Raimondo D; Casadio P; Seracchioli R; Fulgione C; Guida M; Mollo A; Inzani F; Zannoni GF
Pathol Res Pract; 2023 Jul; 247():154515. PubMed ID: 37209572
[TBL] [Abstract] [Full Text] [Related]
9. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
[TBL] [Abstract] [Full Text] [Related]
10. uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
11. HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis.
Bruce SF; Wu S; Ribeiro JR; Farrell A; Oberley MJ; Winer I; Erickson BK; Klc T; Jones NL; Thaker PH; Powell MA
Gynecol Oncol; 2023 May; 172():98-105. PubMed ID: 37003074
[TBL] [Abstract] [Full Text] [Related]
12. Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Change.
Keane E; Floyd R; McDonnell C; Beirne JP; Ó'Riain C; Komanyane L
Int J Gynecol Pathol; 2023 Sep; 42(5):466-471. PubMed ID: 36811845
[TBL] [Abstract] [Full Text] [Related]
13. Estrogen/Progesterone Receptor Loss, ctnnb1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma.
Chibbar R; Foerstner S; Suresh J; Chibbar R; Piche A; Kundapur D; Kanthan R; Kundapur V; Lee CH; Agrawal A; Lai R
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):181-188. PubMed ID: 36695555
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Vermij L; Jobsen JJ; León-Castillo A; Brinkhuis M; Roothaan S; Powell ME; de Boer SM; Khaw P; Mileshkin LR; Fyles A; Leary A; Genestie C; Jürgenliemk-Schulz IM; Crosbie EJ; Mackay HJ; Nijman HW; Nout RA; Smit VTHBM; Creutzberg CL; Horeweg N; Bosse T;
Br J Cancer; 2023 Mar; 128(7):1360-1368. PubMed ID: 36690721
[TBL] [Abstract] [Full Text] [Related]
15. Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swab.
Weimer J; Hüttmann M; Nusilati A; Andreas S; Röseler J; Tribian N; Rogmans C; Stope MB; Dahl E; Mustea A; Stickeler E; Hedemann N; Flörkemeier I; Tiemann K; Magadeeva S; Dempfle A; Arnold N; Maass N; Bauerschlag D
J Cell Mol Med; 2023 Feb; 27(3):379-391. PubMed ID: 36625073
[TBL] [Abstract] [Full Text] [Related]
16. Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis.
Travaglino A; Arciuolo D; Santoro A; Raffone A; Pedone Anchora L; Piermattei A; Martinelli M; Mollo A; Onori ME; Minucci A; Inzani F; Fanfani F; Insabato L; Zannoni GF
Virchows Arch; 2023 Apr; 482(4):671-678. PubMed ID: 36550216
[TBL] [Abstract] [Full Text] [Related]
17. Histopathological and molecular findings in 98 cases of endometrial carcinoma: MMR, p53 and next generation sequencing.
Karabağ S; Şentürk M; Söğüt FC; Ergül ÖS; Ersoy T
Pathol Res Pract; 2023 Jan; 241():154275. PubMed ID: 36528987
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.
van Bommel MHD; Pijnenborg JMA; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; Ligtenberg MJL; Eijkelenboom A; de Hullu JA; Reijnen C
Int J Gynecol Cancer; 2022 Dec; 32(12):1568-1575. PubMed ID: 36384753
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
20. ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
Korentzelos D; Elishaev E; Zhao C; Jones MW; Soong TR; Lesnock J; Orellana T; Zeccola A; Diamantopoulos LN; Wald AI; Bhargava R
Hum Pathol; 2022 Dec; 130():65-78. PubMed ID: 36252860
[TBL] [Abstract] [Full Text] [Related]
[Next]